Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York
- PMID: 32648546
- PMCID: PMC7297691
- DOI: 10.1016/j.annepidem.2020.06.004
Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York
Abstract
Purpose: New York State (NYS) is an epicenter of the SARS-CoV-2 pandemic in the United States. Reliable estimates of cumulative incidence in the population are critical to tracking the extent of transmission and informing policies.
Methods: We conducted a statewide seroprevalence study in a 15,101 patron convenience sample at 99 grocery stores in 26 counties throughout NYS. SARS-CoV-2 cumulative incidence was estimated from antibody reactivity by first poststratification weighting and then adjusting by antibody test characteristics. The percent diagnosed was estimated by dividing the number of diagnoses by the number of estimated infection-experienced adults.
Results: Based on 1887 of 15,101 (12.5%) reactive results, estimated cumulative incidence through March 29 was 14.0% (95% confidence interval [CI]: 13.3%-14.7%), corresponding to 2,139,300 (95% CI: 2,035,800-2,242,800) infection-experienced adults. Cumulative incidence was highest in New York City 22.7% (95% CI: 21.5%-24.0%) and higher among Hispanic/Latino (29.2%), non-Hispanic black/African American (20.2%), and non-Hispanic Asian (12.4%) than non-Hispanic white adults (8.1%, P < .0001). An estimated 8.9% (95% CI: 8.4%-9.3%) of infections in NYS were diagnosed, with diagnosis highest among adults aged 55 years or older (11.3%, 95% CI: 10.4%-12.2%).
Conclusions: From the largest U.S. serosurvey to date, we estimated >2 million adult New York residents were infected through late March, with substantial disparities, although cumulative incidence remained less than herd immunity thresholds. Monitoring, testing, and contact tracing remain essential public health strategies.
Keywords: Coronavirus; Epidemics; Epidemiology; Infectious diseases; Seroepidemiologic studies; Seroprevalence; Surveillance.
Copyright © 2020 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Geographical Profiles of COVID-19 Outbreak in Tokyo: An Analysis of the Primary Care Clinic-Based Point-of-Care Antibody Testing.J Prim Care Community Health. 2020 Jan-Dec;11:2150132720942695. doi: 10.1177/2150132720942695. J Prim Care Community Health. 2020. PMID: 32674696 Free PMC article.
-
COVID-19 Testing, Epidemic Features, Hospital Outcomes, and Household Prevalence, New York State-March 2020.Clin Infect Dis. 2020 Nov 5;71(8):1953-1959. doi: 10.1093/cid/ciaa549. Clin Infect Dis. 2020. PMID: 32382743 Free PMC article.
-
Protocol for a national probability survey using home specimen collection methods to assess prevalence and incidence of SARS-CoV-2 infection and antibody response.Ann Epidemiol. 2020 Sep;49:50-60. doi: 10.1016/j.annepidem.2020.07.015. Epub 2020 Aug 11. Ann Epidemiol. 2020. PMID: 32791199 Free PMC article.
-
Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.Occup Environ Med. 2020 Dec;77(12):857-861. doi: 10.1136/oemed-2020-106676. Epub 2020 Aug 6. Occup Environ Med. 2020. PMID: 32764107
-
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839. JAMA. 2020. PMID: 32648899 Review.
Cited by
-
Quantitating SARS-CoV-2 Neutralizing Antibodies from Human Dried Blood Spots.bioRxiv [Preprint]. 2024 Apr 2:2024.03.18.585599. doi: 10.1101/2024.03.18.585599. bioRxiv. 2024. Update in: Microbiol Spectr. 2024 Oct 29:e0084624. doi: 10.1128/spectrum.00846-24 PMID: 38562708 Free PMC article. Updated. Preprint.
-
Redefining serological diagnostics with immunoaffinity proteomics.Clin Proteomics. 2023 Oct 12;20(1):42. doi: 10.1186/s12014-023-09431-y. Clin Proteomics. 2023. PMID: 37821808 Free PMC article. Review.
-
Evaluation of Ortho VITROS and Roche Elecsys S and NC Immunoassays for SARS-CoV-2 Serosurveillance Applications.Microbiol Spectr. 2023 Aug 17;11(4):e0323422. doi: 10.1128/spectrum.03234-22. Epub 2023 Jun 22. Microbiol Spectr. 2023. PMID: 37347180 Free PMC article.
-
Demographic, social, and behavioral correlates of SARS-CoV-2 seropositivity in a representative, population-based study of Minnesota residents.PLoS One. 2023 Jun 15;18(6):e0279660. doi: 10.1371/journal.pone.0279660. eCollection 2023. PLoS One. 2023. PMID: 37319239 Free PMC article.
-
Estimating the Under-ascertainment of COVID-19 cases in Toronto, Ontario, March to May 2020.J Public Health Res. 2023 May 12;12(2):22799036231174133. doi: 10.1177/22799036231174133. eCollection 2023 Apr. J Public Health Res. 2023. PMID: 37197719 Free PMC article.
References
-
- JHU COVID-19 United States Cases 2020. https://coronavirus.jhu.edu/us-map
-
- Health NYSDo NYSDOH COVID-19 Tracker 2020. https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOV...
-
- Amid Ongoing COVID-19 Pandemic . 2020. Governor Cuomo outlines blueprint to Un-PAUSE New York [press release]https://www.governor.ny.gov/news/amid-ongoing-covid-19-pandemic-governor...
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous

